Clinical Trials in Austin

Showing 10801-10820 of 15,205 trials

Bioequivalency Study of 7.5 mg Pilocarpine Under Fed Conditions

NCT00618059

The objective of this study was the bioequivalence of a Roxane Laboratories' Pilocarpine tablets, 7.5 mg, to SALAGEN® Tablets, 7.5 mg (MGI) under fed conditions using a single-dose, randomized, 2-treatment, 2-period, 2-sequence crossover design.

Dry Mouth

Roxane Laboratories28 participantsStarted Aug 2004

Austin, Texas, United States

COMPLETEDNA< 1 mile

Bioequivalency Study of Mycophenolate Mofetil 250 mg Capsules Under Fasted Conditions

NCT00893542

The objective of this study was to prove the bioequivalence of Mycophenolate Mofetil 250 mg Capsules under fasted conditions.

Prophylaxis of Organ Rejection

Roxane Laboratories37 participantsStarted Nov 2005

Austin, Texas, United States

COMPLETEDNA< 1 mile

Bioequivalency Study of Buprenorphine Hydrochloride 8 mg Tablet Under Fasted Conditions

NCT00992095

The objective of this study was to prove the bioequivalence of Buprenorphine HCl 8 mg tablet under fasted conditions.

Opioid-Related Disorders

Roxane Laboratories48 participantsStarted Aug 2006

Austin, Texas, United States

COMPLETEDNA< 1 mile

Bioequivalency Study of 5 mg Piolocarpine Tablets Under Fed Conditions

NCT00601211

The objective of this study was the bioequivalence of a Roxane Laboratories' Pilocarpine Tablets, 5 mg, to SALAGEN® Tablets, 5 mg (MGI Pharma) under fed conditions using a single-dose, 2-treatment, 2-period, crossover design.

Dry Mouth

Roxane Laboratories28 participantsStarted Sep 2003

Austin, Texas, United States

COMPLETEDNA< 1 mile

Bioequivalency Study of Zidovudine Under Fasting Conditions

NCT00602550

The objective of this study was to assess the bioequivalence of Roxane's zidovudine 300 mg tablet compared to GlaxoSmithKline's Retrovir® 300 mg tablet under fasting conditions using a single-dose, randomized, 2-treatment, 2-period, 2-sequence crossover design.

HIV Infections

Roxane Laboratories52 participantsStarted Jun 2003

Austin, Texas, United States

Bioequivalency Study of 7.5 mg Pilocarpine Under Fed Conditions

Bioequivalency Study of Mycophenolate Mofetil 250 mg Capsules Under Fasted Conditions

Bioequivalency Study of Buprenorphine Hydrochloride 8 mg Tablet Under Fasted Conditions

Bioequivalency Study of 5 mg Piolocarpine Tablets Under Fed Conditions

Bioequivalency Study of Zidovudine Under Fasting Conditions

Find Trials by Condition in Austin

Deviating the Esophagus in Atrial Fibrillation Ablation

Bioequivalency Study of 50 mg Cilostazol Tablets Under Fasting Conditions

Steady State Study of Codeine Sulfate

Bioequivalency Study of Mycophenolate Mofetil 500 mg Tablets Under Fasted Conditions

Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg /25 mg Tablet Under Fed Conditions

Bioequivalency Study of 100 mg Cilostazol Tablets Under Fasting Conditions

Bioequivalency Study of Mycophenolate Mofetil 500 mg Tablets Under Fed Conditions

Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate

A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma.

A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV)

Study to Assess the Tolerability and the Safety of the Transition From Inhaled Treprostinil to Oral Selexipag in Patients With Pulmonary Arterial Hypertension

Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects

Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung)

A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

The Use of High Resolution Chest Computed Tomography in Alpha-1 Antitrypsin Deficiency